healthy4u

We just discussed how the new CEO of the National Quality Forum was revealed to be a member of the board of directors of Premier Inc, and d...

The march of legal settlements by large health care organizations goes on, albeit with ever more quiet footsteps as the number of journalis...

In late 2009, I posted about problems at a Genzyme plant that manufactured some fabulously expensive drugs, e.g. Cerezyme whose cost to pat...

I recently posted about the multiple conflicts of interest affecting a university health sciences leader.  While he was supposed to be runn...

This may be a first.  A small group of Duke University divinity students publicly protested the compensation given to some top university le...

In late 2009, we posted about problems at a Genzyme plant that manufactured some fabulously expensive drugs, e.g. Cerezyme whose cost to pa...

In late 2009, we posted about problems at a Genzyme plant that manufactured some fabulously expensive drugs, e.g. Cerezyme whose cost to pat...

This is the latest in our informal series on the cross-linkages between the thinking and leadership that lead to the global financial collap...

Recently, we posted about misadventures of the leadership of biotechnology giant Genzyme.  Although the company has long priced its drug Ce...

In June, 2009, an article in the Boston Globe described how the Boston area based biotechnology company Genzyme sold some astonishlingly ex...